Skip to content

A Comparative Study of Effects of Platelet-Rich Plasma (PRP) Injection and mixed human acellular dermal matrix (ADM) & PRP Injection in Patients with Lateral Epicondylitis : prospective randomized controlled trial

A Comparative Study of Effects of Platelet-Rich Plasma (PRP) Injection and mixed human acellular dermal matrix (ADM) & PRP Injection in Patients with Lateral Epicondylitis : prospective randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0009547
Enrollment
66
Registered
2024-06-18
Start date
2024-07-01
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : The allogeneic dermal collagen and platelet-rich plasma mixed injection treatment group will use commercialized allogeneic dermal collagen (Esten injection 1cc, L&C Bio), and the p

Sponsors

The Catholic University of Korea, Yeouido St. Mary's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1) Yeouido St. Mary’s Hospital Orthopedic Outpatient 2) Adult male over 20 years of age as of the date of consent 3) A patient who complains of symptoms of elbow trauma and a partial rupture of the common extensor tendon was confirmed on MRI taken during routine medical treatment. 4) Those who understand the research and can voluntarily consent

Exclusion criteria

Exclusion criteria: 1) If there are other diseases that cause elbow joint pain other than traumatic epicondylitis on MRI (fracture, infection, neuropathy, medial epicondylitis, arthritis, etc.)

Design outcomes

Primary

MeasureTime frame
elbow joint range of motion

Secondary

MeasureTime frame
VAS pain score;Patient rating lateral epicondylitis score

Countries

Korea, Republic of

Contacts

Public ContactJong Ho Kim

The Catholic University of Korea, Yeouido St. Mary's Hospital

katris@naver.com+82-2-3779-1194

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026